Status:
NOT_YET_RECRUITING
AUTOANTIBODIES AND SYSTEMIC SCLEROSIS
Lead Sponsor:
IRCCS Ospedale San Raffaele
Conditions:
Understand Pathogenicity of SSc-specific Antibodies in SSc and the Effect of Antibody Blockade in Vitro
Eligibility:
All Genders
18-80 years
Brief Summary
Established in vitro assays, combined with state-of-the-art multi-omics approaches and innovative in vitro experimental models, will gain insights into the mechanistic bases underlying Systemic Sclero...
Eligibility Criteria
Inclusion
- positivity of autoantibodies
Exclusion
- pregnant
Key Trial Info
Start Date :
September 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT06502678
Start Date
September 1 2024
End Date
December 31 2025
Last Update
July 16 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.